After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

“Emphysema is part of a group of lung conditions which comes under the umbrella term chronic obstructive pulmonary disease ...

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

27, 2024 — A recent trial finds an injection given during some asthma and COPD ... inhalers that relax the airways and make it easier to breathe -- do little to help people who do not have ...

Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.

Dr. Andy Whittamore, a GP and clinical lead at Asthma and Lung UK, shed light on four chronic lung conditions that tend to ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges.

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Despite these and other positive pieces of evidence provided by publications in the last decade, inhaled CS have not ... 34 (2–7 years of age) CI = moderate-severe Budesonide 2 mg × 1 (neb ...

When patients cannot adhere to inhaler instructions — whether because of cognitive or physical limitations — a nebulized LAMA might offer another method to safely deliver medication. To that end, GOLD ...

(HealthDay News) — For patients with chronic obstructive pulmonary ... a twice-daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once-daily dry powder inhaler for treatment of ...